Acute toxicity of moderate hypofractionated radiotherapy in localized carcinoma prostate: An observational study
Moderately hypofractionated radiotherapy for localized prostate cancer is well tolerated with manageable acute toxicities. Larger trials with more patients and longer follow-ups may be required to confirm the results and evaluate late toxicities and tumor control in our population.
Authors
- Jagathnath Krishna Kumarapillai Mohanan Nair
- Francis V. James (ORCID: https://orcid.org/0000-0002-0556-4492)
- Aswin Kumar (ORCID: https://orcid.org/0000-0002-8794-1975)
- John Joseph (ORCID: https://orcid.org/0000-0001-6424-2613)
- Kiran Paskalice
Institutions
- Regional Cancer Center, Thiruvananthapuram (IN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_846_24
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00